Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
    May 2023
  1. RICHARD M, Amiens P, Arregle F, Courand PY, et al
    Myocardial calcification: a rare consequence of streptococcal toxic shock.
    Lancet. 2023;401:1691.
    >> Share

    April 2023
    Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.
    Lancet. 2023;401:1266.
    >> Share

  3. GATTA L, Zullo A, Vaira D
    Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.
    Lancet. 2023;401:1265-1266.
    >> Share

  4. REID M, Yamey G, Goosby E, Jamison D, et al
    Seizing opportunities to end TB: a call for ambition and optimism on World TB Day.
    Lancet. 2023;401:1153.
    >> Share

    March 2023
  5. KIRBY T
    Ruvandhi Nathavitharana: advancing TB diagnostics and advocacy.
    Lancet. 2023;401:990.
    >> Share

  6. KASAEVA T, Dias HM, Pai M
    Fast-tracking progress to End TB: high-level opportunities for investment and action.
    Lancet. 2023;401:975-978.
    >> Share

  7. KEECH C, Miller VE, Rizzardi B, Hoyle C, et al
    Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
    Lancet. 2023;401:843-855.
    >> Share

  8. EDWARDS KM, Decker MD
    An alternative route to pertussis protection?
    Lancet. 2023;401:800-801.
    >> Share

  9. EGEBERG A, Thyssen JP
    The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered.
    Lancet. 2023;401:708-710.
    >> Share

  10. KIMBALL AB, Jemec GBE, Alavi A, Reguiai Z, et al
    Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
    Lancet. 2023;401:747-761.
    >> Share

    February 2023
  11. BURKI T
    "Things have gone seriously wrong": global cholera surges.
    Lancet. 2023;401:633-634.
    >> Share

  12. AZIMINIA N, Soman B, Samoes J, Randhawa R, et al
    A diagnostic conundrum of a "ring of fire": a case of tuberculous perimyocarditis.
    Lancet. 2023;401:470-471.
    >> Share

    January 2023
  13. THOMPSON GR 3RD, Soriano A, Cornely OA, Kullberg BJ, et al
    Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
    Lancet. 2023;401:49-59.
    >> Share

    December 2022
    Cholera surges in Haiti.
    Lancet. 2022;400:1913.
    >> Share

    November 2022
  15. GUINEA J
    Rezafungin and invasive candida infections: a new game changing antifungal?
    Lancet. 2022 Nov 25:S0140-6736(22)02371-6. doi: 10.1016/S0140-6736(22)02371.
    >> Share

  16. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Nov 18:S0140-6736(22)02185-7. doi: 10.1016/S0140-6736(22)02185.
    >> Share

  17. GOODALL RL, Meredith SK, Nunn AJ, Bayissa A, et al
    Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02078.
    >> Share

  18. DHEDA K, Lange C
    A revolution in the management of multidrug-resistant tuberculosis.
    Lancet. 2022 Nov 7. pii: S0140-6736(22)02161.
    >> Share

  19. HAWKEY C, Avery A, Coupland CAC, Crooks C, et al
    Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2022;400:1597-1606.
    >> Share

  20. LANAS A, Santilli F
    Aspirin and Helicobacter pylori interaction.
    Lancet. 2022;400:1560-1561.
    >> Share

  21. JACKSON S, Kabir Z, Comiskey C
    Impact of universal tuberculosis vaccination cessation on the epidemiology of paediatric tuberculosis cases in Ireland from 2011 to 2021.
    Lancet. 2022;400 Suppl 1:S53.
    >> Share

  22. JACKSON S, Kabir Z, Comiskey C
    Divergence in pace of decline in tuberculosis rates among migrants versus non-migrants in Ireland from 2011 to 2020.
    Lancet. 2022;400 Suppl 1:S52.
    >> Share

    October 2022
  23. WIECH T, Reinhard L, Wulf S, Giuffrida AE, et al
    Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)02039.
    >> Share

  24. MOK J, Lee M, Kim DK, Kim JS, et al
    9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial i
    Lancet. 2022;400:1522-1530.
    >> Share

  25. REUTER A, Furin J
    Celebrating choice in the care of people living with drug-resistant tuberculosis.
    Lancet. 2022;400:1489-1491.
    >> Share

    September 2022
  26. DEVI S
    War driving cholera in Syria.
    Lancet. 2022;400:986.
    >> Share

    August 2022
  27. MARKS GB, Horsburgh CR Jr, Fox GJ, Nguyen TA, et al
    Epidemiological approach to ending tuberculosis in high-burden countries.
    Lancet. 2022 Aug 4. pii: S0140-6736(22)01433.
    >> Share

    May 2022
    Eliminating cholera in Haiti.
    Lancet. 2022;399:1928-1929.
    >> Share

    April 2022
  29. PIETER Y, Grijsen ML
    Picturing health: the burden of leprosy in eastern Indonesia.
    Lancet. 2022;399:1588-1599.
    >> Share

  30. KANUNGO S, Azman AS, Ramamurthy T, Deen J, et al
    Lancet. 2022;399:1429-1440.
    >> Share

    March 2022
  31. DHEDA K, Pinto L, Mutsvangwa J, Leung CC, et al
    Accelerate investment and action to find the missing patients with tuberculosis.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00535.
    >> Share

  32. YAKOVENKO V, Brauner R, Votinov E, Goldfarb Y, et al
    Infective endocarditis and thromboses due to antiphospholipid syndrome following acute Q fever.
    Lancet. 2022;399:1154.
    >> Share

  33. WATTS G
    Alberto Garcia-Basteiro: seeking better TB control in Mozambique.
    Lancet. 2022;399:1109.
    >> Share

    February 2022
  34. KUMAR A, Preston N, Phillips R
    Picturing health: Buruli ulcer in Ghana.
    Lancet. 2022;399:786-797.
    >> Share

  35. HEINING D, Plant AJ
    Steroid use in non-pneumococcal and non-Haemophilus bacterial meningitis.
    Lancet. 2022;399:717-718.
    >> Share

  36. VAN DE BEEK D, Brouwer MC, Koedel U, Wall EC, et al
    Steroid use in non-pneumococcal and non-Haemophilus bacterial meningitis - Authors' reply.
    Lancet. 2022;399:718.
    >> Share

  37. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    >> Share

    January 2022
  38. VIGNESHWARAN J, Kumar MS, Raghavan V, Sundari S, et al
    Seizures and sideroblastic anaemia in a patient with multidrug-resistant tuberculosis.
    Lancet. 2022;399:393.
    >> Share

  39. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Lancet. 2022 Jan 18. pii: S0140-6736(21)02724.
    >> Share

    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    >> Share

  41. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

    December 2021
  42. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    >> Share

    November 2021
  43. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    >> Share

    October 2021
  44. BUTLER-LAPORTE G, Halme A, Simard C
    Antibiotic treatment duration for bacteraemic pneumonia.
    Lancet. 2021;398:1485.
    >> Share

  45. DINH A
    Antibiotic treatment duration for bacteraemic pneumonia - Author's reply.
    Lancet. 2021;398:1485-1486.
    >> Share

  46. COUSSEMENT J, Dauby N
    Antibiotic treatment duration for bacteraemic pneumonia.
    Lancet. 2021;398:1484-1485.
    >> Share

  47. HEGDE A, Littlechild P, Taylor W
    Lumbar sediment sign seen in an unusual presentation of meningitis.
    Lancet. 2021;398:1436.
    >> Share

    September 2021
  48. LOW N, Hocking JS, van Bergen J
    The changing landscape of chlamydia control strategies.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)02002.
    >> Share

  49. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016